ST 1435

Known as: ST-1435 
 

Topic mentions per year

Topic mentions per year

1976-1999
02419761999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
A new modified subdermal implant releasing the potent progestin ST-1435 was studied in eleven fertile-aged women. These implants… (More)
Is this relevant?
1991
1991
The synthetic progestin ST-1435 was administered transdermally to six healthy women during the late luteal phase. The steroid was… (More)
Is this relevant?
1990
1990
A subcutaneous contraceptive capsule releasing progestin ST-1435 was used by 6 breast-feeding women. One to three paired milk and… (More)
Is this relevant?
1990
1990
Four women used vaginal rings releasing the synthetic progestin ST-1435 and ethinyl estradiol for at least three 21-day cycles… (More)
Is this relevant?
1985
1985
We summarize the hormonal profiles of women at different stages of inhibition of ovarian function during sustained-release… (More)
Is this relevant?
1984
1984
Nine healthy, fertile women were treated for six months with subdermal contraceptive implants of two different sizes containing a… (More)
  • table 1
  • table 2
Is this relevant?
1984
1984
Seven women used an ST-1435-releasing intracervical contraceptive device (ST-ICD), inserted immediately after the cessation of… (More)
Is this relevant?
1984
1984
The intestinal absorption of a 19-norprogesterone (ST-1435) was studied in rats after an oral dose of 5 mg ST-1435/kg body weight… (More)
Is this relevant?
1984
1984
Plasma levels of ST-1435 were determined by radioimmunoassay in 36 women and three men during treatment with subdermal capsules… (More)
Is this relevant?
1981
1981
An RIA for a new progestin, ST-1435, was developed. Plasma concentrations of this steroid were measured in three women having… (More)
Is this relevant?